Impact of HPV Vaccine On The Prevalence Of HPV In Norway
NCT ID: NCT02934724
Last Updated: 2020-12-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
315 participants
OBSERVATIONAL
2016-11-30
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The womens vaccination status will be validated by linkage to the Norwegian Immunisation Registry (SYSVAK) and their residence status will be validated through linkage to the Norwegian Population Registry.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vaccinated
Women born in 1997, resident to Norway in 2009, vaccinated by the quadrivalent HPV vaccine.
Interventions:
* Self sample from vagina using Rover's Evalyn Brush
* Self sample from the oral cavity using COPAN's FloqSwab
* Questionnaire
Self sample from vagina
Self sample using The Rover's Evalyn Brush
Self sample from the oral cavity
Self sample using COPAN FloqSwab
Questionnaire
Questionnaire about vaccination status and sexual behaviour
Un-vaccinated
Women born in 1997, resident to Norway in 2009, not vaccinated by the quadrivalent HPV vaccine
Interventions:
* Self sample from vagina using Rover's Evalyn Brush
* Self sample from the oral cavity using COPAN's FloqSwab
* Questionnaire
Self sample from vagina
Self sample using The Rover's Evalyn Brush
Self sample from the oral cavity
Self sample using COPAN FloqSwab
Questionnaire
Questionnaire about vaccination status and sexual behaviour
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Self sample from vagina
Self sample using The Rover's Evalyn Brush
Self sample from the oral cavity
Self sample using COPAN FloqSwab
Questionnaire
Questionnaire about vaccination status and sexual behaviour
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Born in 1997
* Resident of Norway in 2009
Exclusion Criteria
* Born before or after 1997
* Non-resident of Norway in 2009
18 Years
20 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Akershus
OTHER
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Espen Enerly
Dr Scient
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Espen Enerly, Dr Scient
Role: PRINCIPAL_INVESTIGATOR
Oslo University Hospital
Giske Ursin, Dr.Med
Role: STUDY_DIRECTOR
Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oslo University Hospital, Cancer Registry of Norway
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
PLOS ONE Staff. Correction: An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway. PLoS One. 2019 Dec 12;14(12):e0226706. doi: 10.1371/journal.pone.0226706. eCollection 2019.
Enerly E, Flingtorp R, Christiansen IK, Campbell S, Hansen M, Myklebust TA, Weiderpass E, Nygard M. An observational study comparing HPV prevalence and type distribution between HPV-vaccinated and -unvaccinated girls after introduction of school-based HPV vaccination in Norway. PLoS One. 2019 Oct 10;14(10):e0223612. doi: 10.1371/journal.pone.0223612. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014/2333
Identifier Type: -
Identifier Source: org_study_id